Viewing Study NCT05918263



Ignite Creation Date: 2024-05-06 @ 7:09 PM
Last Modification Date: 2024-10-26 @ 3:01 PM
Study NCT ID: NCT05918263
Status: RECRUITING
Last Update Posted: 2024-03-21
First Post: 2023-06-14

Brief Title: Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance The REMOVE Trial
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Study Overview

Official Title: Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance The REMOVE Trial
Status: RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine whether a 16-week home-based virtually supervised exercise program will slow cancer progression of prostate cancer among Black men with prostate cancer undergoing active surveillance

The name of the study intervention involved in this study is

Aerobic high-intensity interval training HIIT training exercise intervention
Detailed Description: This research study is a randomized controlled study for a home-based virtually supervised aerobic exercise intervention for Black men with prostate cancer undergoing active surveillance There is evidence that exercise may suppress cancer progression but the evidence is preliminary and Black men with prostate cancer has been highly underrepresented in exercise clinical research despite their higher risk of cancer progression compared to White counterparts

Participants will be randomized into one of two treatment groups Group A Aerobic high-intensity interval training HIIT versus Group B Usual Care Randomization means a participant is placed into a study group by chance

The research study procedures include screening for eligibility study treatment visits survey questionnaires blood tests and follow-up visits

Participation in this research study is expected to last about 18 weeks

It is expected that about 68 people will take part in this research study

The Prostate Cancer Foundation is providing funding for this research study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None